NCT01134770

Brief Summary

The purpose of the study is to understand the biology and behavior of early mother-infant attachment, and to investigate how it may be affected by prenatal substance exposures. The investigators are interested in how drugs such as cocaine, alcohol, marijuana and cigarette smoking affect both mother and baby.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Jul 2008

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Jul 2008Jan 2027

Study Start

First participant enrolled

July 1, 2008

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

May 28, 2010

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 2, 2010

Completed
16.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

February 4, 2026

Status Verified

February 1, 2026

Enrollment Period

18.5 years

First QC Date

May 28, 2010

Last Update Submit

February 3, 2026

Conditions

Keywords

Prenatal Substance UseCocaineCigarette SmokingMothersPregnant womenSmoking Mothers

Outcome Measures

Primary Outcomes (1)

  • Determine the effect of prenatal cocaine exposure on the neonatal brain. ventricular volumes

    2 to 4 weeks of age

Study Arms (3)

Prenatal Cocaine

Use of cocaine at anytime during pregnancy. Subjects may also have used other drugs in combination with Cocaine

Prenatal Nicotine-Alcohol-Marijuana

Subjects may have used any of these drugs during pregnancy, alone or in combination. This group has not used cocaine during pregnancy.

Drug-Free Pregnancy

Subjects did not use any of the following drugs during pregnancy: cocaine, nicotine, alcohol, marijuana.

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women or mothers with their newborn infants.

You may qualify if:

  • During pregnancy, mother has used any of the following:
  • cocaine
  • marijuana and/or alcohol but not cocaine
  • nicotine (smoked cigarettes)
  • no drugs during pregnancy
  • Mother is pregnant or no more than 4 weeks postpartum

You may not qualify if:

  • Mother has cardiovascular disease
  • Delivery before 36 weeks or later than 42 weeks gestation
  • Birth weight less than 5.5 lbs
  • Baby was a multiple birth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Plasma from mothers and buccal cells from infants will be stored for possible DNA analysis of target genes pending additional funding.

MeSH Terms

Conditions

Cigarette Smoking

Condition Hierarchy (Ancestors)

Tobacco SmokingSmokingBehaviorTobacco Use

Study Officials

  • Karen Grewen, PhD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2010

First Posted

June 2, 2010

Study Start

July 1, 2008

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Last Updated

February 4, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations